Industry Analysis Reports | Health Care | Medical Devices

Friday, 19 February 2021

Medical Oxygen Concentrators Market 2021 Analysis By Manufacturers, Latest Trends, Competitive Landscape And Strategies

Key Players

Few of the prominent players in the global medical oxygen concentrators market are Philips Healthcare, AirSep Corporation, Invacare Corporation, Drive DeVilbiss Healthcare, Medtronic plc, ResMed, Chart Industries, Inc., Nidek Medical Products, Inc., Inogen, Precision Medical, Inc., GCE Group, Besco Medical Limited, O2 Concepts, LLC, Teijin Limited, and OSI - Oxygen Solutions Inc.

Market Highlights

The Global Medical Oxygen Concentrators Market held a market value of USD 1,755.8 Million in 2018 and is Projected to Grow at a CAGR of 7.8% Over the Forecast Period. Oxygen concentrator, also called as oxygen generator is a medical device used to deliver oxygen to the patient. This device concentrates the oxygen from a gas supply by removing nitrogen to supply an oxygen-enriched product gas stream. Stationary oxygen concentrators are used as stationary sources to provide long-term oxygen therapy (LTOT) to patients at home. Oxygen concentrators provide supplementary oxygen for patients suffering from a chronic obstructive pulmonary disease (COPD) and in higher concentrations for pulmonary edema and severe chronic hypoxemia. In addition, this device is also used as an adjunct treatment for severe sleep apnea.

Factors driving the market growth are worldwide increasing the number of patients requiring long-term oxygen therapy, rising prevalence of the chronic obstructive pulmonary disease, sleep apnea, and asthma, growth in healthcare spending, growing demand for portable oxygen concentrators, and the presence of favorable government initiatives. For instance, according to the data published by World Bank, in 2010, world’s current healthcare expenditure (% of gross domestic product — GDP) was 9.57% that was soared to 10.02% in 2016. In contrast, the high cost of oxygen concentrators and huge loss of oxygen and energy when continuous flow technology is used are anticipated to impede the market growth over the forecast period. Price range varies from USD 1,100 to 4,000 (2,300 typical) for stationary units and 3,995 to 5,700 (5,000 typical) for portable units.

Portable oxygen concentrators are oxygen machines that draw in oxygen with the use of a battery, electricity or DC power. These oxygen concentrators offer advantages such as compact in size, lightweight, improved efficiency, cost economic price, and mobility that enables patients to travel hassle-free. Technological advancements in the portable oxygen concentrators include pressure swing adsorption (PSA), and membrane technology is helping in the swift adoption of portable medical oxygen concentrators.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/medical-oxygen-concentrators-market-7876

Segmentation

The global medical oxygen concentrators market has been segmented into product, technology, indication, end user, and region.

By product, the market has been segmented into portable oxygen concentrators and stationary oxygen concentrators.

On the basis of technology, the market has been divided into the continuous flow and pulse dose.

Based on indication, the market has been categorized into chronic obstructive pulmonary disease, asthma, sleep apnea, and others.

By end user, the market has been classified into homecare, travel, hospitals and clinics, and others. Home oxygen concentrators facilitate convenience and make it easier and safer for the patient to complete their day-to-day activities, which is supporting the dominance of the homecare segment during the next six years.

Regional Analysis

The global medical oxygen concentrators market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas is expected to dominate the market over the forecast period due to the presence of favorable government initiatives, reimbursement policies, and major market participants developed home healthcare care services and higher adoption of portable oxygen concentrators for homecare needs. Higher value contributors based in the US are Philips Healthcare, Invacare Corporation, AirSep Corporation, ResMed, and Precision Medical, Inc. In addition, government initiatives including the presence of the Federal Aviation Administration (FAA), which authorize the use of portable concentrators during air travel are promoting the dominance of the Americas.

Europe would follow the Americas in terms of revenue over the forecast period as the German government has been undertaking several initiatives to reduce pollution levels in the country and promote public health. In November 2018, the German government unveiled a 5-point plan to reduce plastic waste.

The market in Asia-Pacific would showcase comparatively higher CAGR during the forecast period. This is owing to rising prevalence of COPD and asthma, increasing spending on healthcare, growing awareness about state-of-the-art technologies in an oxygen concentrator, rising adoption of portable units, growth in disposable income, and changing diet pattern and lifestyle resulting in the development of diseases. As per data published in The Lancet journal, in 2016, the prevalence of COPD in India was 4·2% and the prevalence of asthma 2·9%. India has a higher prevalence of COPD than the global average, as well as more disability-adjusted life-years (DALYs) per person with COPD or asthma than the global average.

The Middle East & Africa has the least share of the global medical oxygen concentrators market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

Veterinary/Animal Vaccines Market Size, Share and Forecast to 2025

Veterinary/Animal Vaccines Market Information: By Type (Livestock Vaccines, Porcine Vaccines), Technology (Live Attenuated Vaccines, Inactivated Vaccines), and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa)—Global Forecast till 2025

Overview:

Be it as a means for food or as pets, animals have an age-old relationship with human beings. That is why the well-being of these animals become all the more necessary. Hence, veterinary vaccines are gaining traction across the Middle East & Africa (MEA). Veterinary vaccines ensure improved health and increased production of the livestock and reduce cost substantially. At the same time, it prohibits the transmission of diseases to other animals or human beings. Climate is playing a crucial role in triggering growth in number of the cases registered with animals getting affected by diseases. The second factor constantly influencing the market is the increase in spending on companion animals. This makes the owners seek assistance to apply veterinary vaccines to their animals to ensure their healthy life as well as of people around the animal. The region has a huge number of unvaccinated livestock which is becoming a concern as the dairy and meat sectors are also burgeoning. Hygiene has always been a problem with this region, and this can result in animals getting affected by diseases. And factors can have a knock-down effect on the MEA veterinary vaccines market and aid it to inflate with CAGR 7.1% during the forecast period (2013-2022) to reach USD 550.84 million, asserts Market Research Future (MRFR) in a detailed study.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/2687

However, research and development in this sector can incur high investment which considering the end price of products may not seem beneficial. This can give the veterinary vaccines market an unwanted jolt. The market is also getting steep competition from its Chinese counterparts, and the animal industry is fairing poorly as Europe is gaining the upper hand in the region.

Segmentation:

The MEA market for veterinary vaccines can be segmented by technology, disease indication, composition, and animal type.

Technology-wise, the market can be segmented into attenuated, inactivated, toxoid, conjugate, subunit and recombinant DNA. Growing number of farms and animals as companions have given rise to attenuated segment which is currently dominating the market and the situation is expected to remain so in the foreseeable future.

Based on disease indication, the market includes foot & mouth disease, parvovirus, distemper, reproductive & respiratory syndrome and others.

Composition-based segmentation comprises mono vaccine and combination vaccines.

Based on animal type, the market consists poultry, bovine, porcine, companion and other. Poultry segment is accounted for the maximum market share followed by porcine. Meanwhile, companion section is witnessing significant market growth owing to the trend of adoption of pets.

Access Report @ https://www.marketresearchfuture.com/reports/mea-veterinary-vaccines-market-2687

Regional Analysis:

The MEA market for veterinary vaccines can be segmented into the UAE, Egypt, Saudi Arabia, Kuwait, Qatar, and Oman.

The UAE has the largest market for veterinary vaccines. The region has a well-formed healthcare setup that looks into the issue, and people with disposable income are also fond of pets which give the market considerable leverage in exploring significant possibilities.

Egypt is currently holding the second position. The local market here is driven by growing demand for meat and dairy product and to safeguard the source of such food and beverage, vaccines are necessary. Weather in the African continent is harsh but is ideal for diseases which spreads quite rapidly. Animals and human beings living in close proximity also increase chances of infection transmission which has to be taken into consideration for a better lifestyle.

Market Competition:

The market is getting some recognition from the concerned authorities as it can benefit from the associated industries significantly. Presence of several foreign companies in the region is also proving vital for the market.

Some of the key players in this market are Zoetis Inc., Boehringer Ingelheim GmbH, Merck Animal Health, MSD Animal Health, Elanco Animal Health, Bayer AG, Indian Immunologicals Limited, and others.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Positron Emission Tomography Devices (PET) Market Trends| global Analysis - MRFR

Market Highlights

The global positron emission tomography devices (PET) market is expected to grow at an approximate CAGR of 5.6% during forecast period, 2018–2023.

Increasing cases of head and neck cancer is the key factor driving the positron emission tomography devices (PET) market. According to the 2018 data suggested by the Australian Institute of Health and Welfare, around 5,091 new cases of head and neck cancer were diagnosed and around 1,034 number of deaths occurred from head and neck cancer in Australia.

Various other factors such as increasing cases of cancer, technological advancements, presence of a large target patient population and rising patient awareness regarding the benefits of positron emission tomography scanning are also expected to propel the growth of the market.

However, stringent regulatory guidelines, cost associated with PET scan, and shorter half-life of radioisotopes can hamper the market growth over the forecast period.

Segmentation

The global positron emission tomography devices (PET) market is segmented based on product type, applications, end user and region.

The global market for positron emission tomography devices (PET), by product type is segmented into full ring PET scanners and partial ring PET scanners.

The market, by applications, is segmented into cardiology, neurology, oncology, orthopaedics, urology, gastroenterology, and others

Based on end user, positron emission tomography devices (PET) market is segmented into hospitals, clinics, diagnostic centres, and others.

Regional Analysis

The Americas dominated the global market for positron emission tomography devices (PET) owing to presence of major market players and increased prevalence of Alzheimer's dementia within the region. As per the data suggested by the Alzheimer's Association, an estimated 5.7 million Americans of all ages are living with Alzheimer's dementia in 2018.

Europe is expected to hold the second largest position in the global positron emission tomography devices (PET) market. The market growth in this region is attributed to the government support and improving healthcare related research & development activities.

Asia Pacific was projected to be the fastest growing region in 2017. Factors such as, growing cases of head and neck cancer, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region.

On the other hand, the Middle East and Africa held least share in the global positron emission tomography devices (PET) market due to the low per capita income, especially within the African region.

Key Players

Some of the key players in the global positron emission tomography devices (PET) market are Agfa Healthcare, Gamma Medica Inc., GE Healthcare, Neusoft Medical Systems, Oncovision, Koninklijke Philips N.V., Positron Corporation, Siemens AG, Segami Corporation, Spectrum Dynamics Ltd., Naviscan, Inc. MedX Holdings Inc., Modus Medical Devices Inc., Radiology Oncology Systems, Inc., Yangzhou Kindsway Biotech Co. Ltd., Toshiba Corporation, Hitachi, Ltd., and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/positron-emission-tomography-devices-market-7254

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Thursday, 18 February 2021

News - Global Neonatal Thermoregulation Market Size, Demand, Analysis and Forecast

Market Highlights:

It is estimated that the Global Neonatal Thermoregulation Market is expected to hold a market value of USD 500 million and register a CAGR ~ 5.0 % during the forecast period of 2018–2023. Thermoregulation is the ability to create equilibrium between heat production and heat loss in order to maintain body temperature within a certain normal range. The provision of a thermoneutral environment is an essential component of the immediate and long-term care of newborn infants. With the surge in the birth rates of newborns, the equipment used for blood sampling and monitoring the baby is steadily increasing. According to a data published by the Centers for Disease Control and Prevention in January 2017, there were 3,945,875 births in the US in 2017. This means birth rate in US in 2017 was 12.2 per 1000 population. Moreover, rising prevalence of diseases in neonates fuels the growth of the market. However, stringent government regulation for product approval and possible side-effects for the neonates may hamper the market growth during the assessment period.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/6913

The global neonatal thermoregulation market is currently dominated by many market players. The key players in the market are engaged in new product launches and strategic collaborations to strengthen its market position. For instance, in November 2016, Drägerwerk AG & Co. KGaA introduced IncuWarmer Babyleo TN500 which offers optimal thermoregulation in open care, closed care and transition to the premature baby.

Regional Analysis:

The Americas is anticipated to dominate the global neonatal thermoregulation market owing to a well-developed healthcare sector, and rising prevalence of diseases. The involvement of government in creating awareness about the neonatal diseases also fuels the growth of the market. For instance, US government has programs like Screening Quality Assurance Programs and Heritable Disorders Program at Health Resources and Service Administration (HRSA). Thus, such initiatives and programs by the government as well as non-government organizations support the market growth. Europe is expected to hold the second largest position in the global neonatal thermoregulation market. The market growth in this region is attributed to the availability of funds for research. Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population, and continuously developing economies, According to a report published by the International Journal of Social and Developmental Concerns in October 2017, in Malaysia, growth of the public primary as well as secondary care facilities has decreased in the past few years and it has not kept pace with the rapid urbanization. Thus, such factors restraint the growth of the market in this region. On the other hand, the Middle East & Africa has the least share of the market.

Segmentation:

The Global Neonatal Thermoregulation Market has been segmented into product type, modality, end-user, and region.The market, on the basis of product type, has been segmented into warmer, neonatal incubators, and neonatal cooling systems.The market, based on warmer, has been further segmented into radiant warmers and wall mount warmer.

The market, by neonatal incubators, has been sub-segmented into intensive care incubator and transport incubator.The market, by modality, has been segmented into open and closed.The market, by end-user, has been segmented into hospitals, pediatric and neonatal intensive care units, nursing homes, and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/neonatal-thermoregulation-market-6913

Key Players:

Some of the key players in the global neonatal thermoregulation market are Koninklijke Philips N.V., GENERAL ELECTRIC COMPANY, Natus Medical Incorporated, Inspiration Healthcare Group plc., , Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare, International Biomedical, Ltd., Atom Medical Corporation, Fanem Ltd, and Novos Medical Systems.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Microcarriers Market Revenue, Global Opportunities, Emerging Technologies, Future Prospects and Forecast 2023

Market Highlights:

The Global Microcarrier Market is anticipated to hold a market value of USD 1.18 billion with an estimated CAGR of 5.9% during the forecast period. A microcarrier is a support matrix allowing the growth of adherent cells. The microcarrier system provides high cell yields without having to resort to bulky equipment and tedious methodology. The rise in the use of microcarrier technology for various cell-based applications, coupled with the advantages of the microcarrier system such as its support for high yield of cells, facilitation of polarization and differentiation of cells, and lower risk of contamination are expected to drive the growth of the market during the forecast period. Moreover, the rapid growth of the biologics industry also fuels the growth of this market. On the other hand, strict regulatory framework, and limitation in production of high-density cell culture may hinder the growth of the market during the forecast period.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/6911

The global microcarrier market is currently dominated by many market players. These players are engaged in new product launches and strategic collaborations to strengthen its market position. For instance, in March 2018, Danaher announced that it has entered into a definitive agreement to acquire Integrated DNA Technologies, a privately-held provider of high-value consumables for genomics applications in next generation sequencing, synthetic biology, molecular biology, gene editing and molecular diagnostics.

Regional Analysis:

The market in the Americas is expected to dominate the global Microcarrier market during the forecast period owing to the increasing incidence of cancer and other chronic diseases, a well-developed healthcare sector and growing number of venture capital investments. According to data published by Centers for Disease Control and Prevention (CDC), 1,633,390 new cases of cancer were reported in the year 2015, and 595,919 people died of cancer in the United States in the same year. The European market is expected to be the second-largest due to government funding and support of the healthcare sector coupled with the strategic expansion of biopharmaceutical companies in this region. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the assessment period owing to growing disposable income and rising demand for cell-based vaccines. The market in the Middle East and Africa is likely to account for the smallest share of the global microcarrier market. The market growth in this region can be attributed to the growing government initiatives.

Segmentation:

The global microcarriers market has been segmented into product type, application, and end-user.The market, on the basis of type, has been segmented into equipment, and consumables.The market, based on equipment, has been segmented into bioreactors, culture vessels, cell counters, filtration systems, and other equipment.The market, based on consumables, has been sub-segmented into media, reagents, and microcarrier beads.The market, based on media, has been further segmented into serum-based media, serum-free media, and other media.

The market, based on microcarrier beads, has been sub-segmented into cationic microcarriers, collagen-coated microcarriers, protein-coated microcarriers, and other microcarrier beads.The market, on the basis of application, has been further segmented into vaccine manufacturing, cell therapy, biologics manufacturing, and other applications.The market, on the basis of end-user, has been further segmented into pharmaceutical and biotechnology companies, research institutes, and contract research organizations.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/microcarriers-market-6911

Key Players

Some of the key players in the global microcarrier market are Thermo Fisher Scientific Inc., Lonza, GENERAL ELECTRIC COMPANY, Corning Incorporated, Sartorius AG, Danaher, Merck KGaA, Becton, Dickinson and Company, Eppendorf AG and HiMedia Laboratories.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com .

Urgent Care Apps Market Expected to Grow at a CAGR of 42.20% up to 2023 | Regional Analysis, Key Players, Industry Segments and Competitors Strategy

Market Research Future has published a half-cooked research report on the Global Urgent Care Apps Market.

The Global Urgent Care Apps Market continues on a gradual upward trajectory and is expected to cross USD 2595 Mn mark by the end of 2023. The global urgent care apps market stood at USD 314.2 Mn in 2017 and Market Research Future (MRFR) anticipates dynamite growth in the market with a CAGR over 42.20% over the forecast period which ends in 2023.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/6677

Urgent care apps are advantageous in managing medical conditions which need immediate attention. They act as an additional pathway for medical conditions which require prompt action but are non-life-threatening concerns. They offer an effective and low-cost option for the management of health conditions such as pregnancy, stroke, cardiac diseases, trauma, and others. Multiple use cases presented by urgent care apps are boosting the growth of the market. Also, these apps have been proven beneficial in post-hospital or post-operative care among patients.

The ubiquity of smartphones coupled with the growing penetration of 3G and 4G networks, especially in the emerging economies are contemplated to be reflecting positively on the growth of the global urgent care apps market. The digital revolution in healthcare is speeding up the adoption of urgent care apps and consequently fostering market growth.

The gradual shift in focus on personalized and patient-centric healthcare delivery has been a key driver for the growth of the global urgent care apps market. Urgent care apps deliver a diverse set of services with more flexible hours. They are particularly useful for elderly patients who require reassurance and offer them with access to immediate help during emergencies.

Raising awareness regarding the availability of medication management apps in combination with the factors mentioned above add fuel to the growth of the global urgent care apps market.

However, the market might be met by some challenges including the bulk of miscategorized apps in the App Store & Google Play and poor internet connectivity issues in underdeveloped regions which restrict the growth of the market.

Segmentation

The Global Urgent Care Apps Market has been segmented based on type and clinical area.

By type, the urgent care apps market has been segmented into emergency care triage apps, in-hospital communication & collaboration apps, and post-hospital apps. The post-hospital apps segment has been further segmented into medication management apps, care provider communication & collaboration apps, and rehabilitation apps.

By clinical area, the global urgent care apps market has been segmented into trauma, stroke, cardiac conditions, and others. The trauma segment is the largest segment on account of rising incidences of road accidents which necessitates trauma care and increasing awareness to address trauma by healthcare organizations. The cardiac conditions segment is expected to be the fastest growing segment owing to the gradual realization of the benefits of urgent care apps in the management of critical cardiac conditions.

Regional Analysis

The Americas, Europe, Asia Pacific, and the Middle East & Africa are the key markets for urgent care apps.

North America is a significant market for urgent care apps, led by North America. Deep penetration of smartphones and 3G and 4G networks along with escalating healthcare cost and constant need to address the same are augmenting the market in North America. Moreover, the region tends to quickly adapt to emerging technologies which further supports the growth of the urgent care apps market. Other driving factors include raising awareness and increasing focus on personalized healthcare.

Europe's market growth can be exclusively attributed to increasing initiatives by the government towards the promotion of such apps and towering need to curtail healthcare costs. Germany, Italy, France, Spain, and the UK are the major markets in Europe.

Asia Pacific market for urgent care apps is anticipated to have an expeditious growth in the coming years. Growing penetration of smartphones in the emerging economies of Asia Pacific coupled with raising awareness about healthcare management apps can be accredited for the growth of the urgent care apps market in Asia Pacific.

Access Report Details @ https://www.marketresearchfuture.com/reports/urgent-care-apps-market-6677

Competitive Landscape

Some of the prominent players operating in the global urgent care apps market include Forward Health, Pivot Design Group, Johnson & Johnson, Twiage, Siilo, Alayacare, PatientSafe Solutions, Vocera Communications, Hospify, Argusoft, Voalte, Pulsara, Imprivata, Allm, and TigerConnect.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

News: healthcare cloud computing market Trends and Regional Forecast

Market Insights

Cloud computing offers several important benefits which have significantly impacted the general market for cloud-based technologies. The various features of the cloud deployment of IT software increase the collection of data in real-time and significantly improves data retrieval among other things. Market Research Future has deeply examined the global healthcare cloud computing market to understand the various factors that influence growth in its upcoming report on the subject. Document processing is an ongoing task in healthcare facilities and the speed and efficiency that cloud computing offers has increased the adoption of the same.

Cloud computing reduces overall costs as it is used without the need for physical infrastructure. The internet is used to store and manage data which also cuts down on maintenance costs. This is a significant driver of the global healthcare cloud computing market. The IT revolution and widespread growth of and demand for cloud computing has affected the healthcare sector in a highly positive manner. The large amounts of data generated in healthcare has encouraged the adoption of cloud computing. The generation of large volumes of data has increased further with high adoption of Scalability and flexibility are some of the growth driving factors in the global healthcare cloud computing market. Major healthcare cloud computing players are actively involved in the development of new and improved services which will continue to optimize operations in large and complex industries such as healthcare. Security risks and the concern regarding sensitive data being made available on the cloud is expected to restrain market growth. Cloud breaches with regards to data and inefficient backup activities undertaken by healthcare organizations are likely to pose challenges to market growth, which may be addressed to some extent in the coming years.

Access Report @ https://www.marketresearchfuture.com/reports/healthcare-cloud-computing-market-6519

Market Segmentation

The global healthcare cloud computing market is segmented in MRFR's report on the basis of applications, deployment, service, end-user, and region. Healthcare cloud computing has two key applications, namely Non -Clinical Information System (NCIS), and Clinical Information System (CIS). The CIS segment is further sub-segmented to include electronic health records (EHR), pharmacy information system (PIS), computerized physician order entry system (CPOE), and others.

Deployment of healthcare cloud computing segmented into private cloud, public cloud, and hybrid cloud. Healthcare cloud computing makes its possible to offer services in various innovative forms which include Software-As-A-Service, Infrastructure-As-A-Service, and Platform-As-A-Service. Healthcare providers and healthcare players make up the end-users of healthcare cloud computing .

The global healthcare cloud computing market is segmented by region into Europe, Latin America, North America, the Asia Pacific and the Middle East and Africa.

Regional Analysis

North America due to its inclusion of the U.S where there is a high concentration of market players and the presence of a significant healthcare sector is expected to be a significant market in the global healthcare cloud computing market. North America has a well-established healthcare sector due to the concentration of developed economies in the region. The region also displays an affinity for the adoption of advanced technology.

The Asia Pacific is a rapidly growing market due to the presence of a rapidly developing healthcare sector in the region. Countries such as India and China are among the most populous countries in the world which have a massive patient population. The need to have efficient operations in treating these masses is expected to encourage the adoption of advanced healthcare cloud computing solutions during the forecast period.

Key Players

Eminent market players that have been included in MRFR’s analysis of the competitive landscape include GE Healthcare, Athena Health Inc., IBM Corporation, Sectra AB, CareCloud Corporation, Carestream Corporation, Agfa-Gevaert N.V., NextGen Healthcare, ClearData Networks Inc., Nuance Communications, Oracle Corporation, Siemens Healthineers, Microsoft Corporation, Cerner Corporation, Merge Healthcare Inc., and Dell Inc.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Industry Analysis Reports | Health Care | Medical Devices | Pharmaceutical

Labels

Friday, 19 February 2021

Medical Oxygen Concentrators Market 2021 Analysis By Manufacturers, Latest Trends, Competitive Landscape And Strategies

Veterinary/Animal Vaccines Market Size, Share and Forecast to 2025

Positron Emission Tomography Devices (PET) Market Trends| global Analysis - MRFR

Market Highlights

Thursday, 18 February 2021

News - Global Neonatal Thermoregulation Market Size, Demand, Analysis and Forecast

Microcarriers Market Revenue, Global Opportunities, Emerging Technologies, Future Prospects and Forecast 2023

Urgent Care Apps Market Expected to Grow at a CAGR of 42.20% up to 2023 | Regional Analysis, Key Players, Industry Segments and Competitors Strategy

News: healthcare cloud computing market Trends and Regional Forecast

Blog Archive

Total Pageviews